Measuring Evidence-Based Viral Respiratory Illness Mitigation Behaviors in Pregnant Populations: Development and Validation of a Short, Single-Factor Scale During the COVID-19 Pandemic.
Measuring Evidence-Based Viral Respiratory Illness Mitigation Behaviors in Pregnant Populations: Development and Validation of a Short, Single-Factor Scale During the COVID-19 Pandemic.
复制标题
测量孕妇循证病毒性呼吸道疾病缓解行为：在 COVID-19 大流行期间开发和验证简短的单因素量表。
DOI：
10.1017/dmp.2022.103
复制
发表时间：
2022
影响因子：
2.7
通讯作者：
Simmons,LeighAnn
中科院分区：
文献类型：
--
作者：
Whipps,MackenzieDM;Phipps,JenniferE;Simmons,LeighAnn
研究人员和公共卫生专业人员需要更好地了解个人参与2019冠状病毒病（COVID-19）缓解行为，以减少当前流行病的人类和社会成本，并为未来的呼吸道流行病做好准备。我们建议，制定个人缓解行为的措施，并在高风险人群（包括孕妇）中进行测试，可能有助于通过快速确定缓解信息的目标，直到达到足够的疫苗接种率，从而降低总体发病率和死亡率。MethodsWe调查了加州的孕妇，调查了COVID-19大流行的2波，以探索缓解行为。我们开发并验证了一种新的病毒性呼吸道疾病缓解量表（VRIMS）。ResultsSeven措施加载到一个单一的因素，具有良好的心理测量特性。总体样本规模的平均值在两个波都很高，这表明大多数怀孕的加州人在大多数时间里都采用了大多数策略。老年参与者、少数群体参与者、生活在城市环境中的参与者以及在激增期间接受调查的参与者报告说，他们最常使用这些策略。结论临床医生和研究人员应考虑使用可靠、经过验证的措施，如VRIMS，以确定可能受益于关于降低COVID-19、未来呼吸道大流行甚至季节性流感风险的额外教育的个人和社区。
ObjectiveResearchers and public health professionals need to better understand individual engagement in coronavirus disease 2019 (COVID-19) mitigation behaviors to reduce the human and societal costs of the current pandemic and prepare for future respiratory pandemics. We suggest that developing measures of individual mitigation behaviors and testing them among high-risk individuals, including pregnant people, may help to reduce overall morbidity and mortality by quickly identifying targets for messaging around mitigation until sufficient vaccination uptake is reached.MethodsWe surveyed pregnant people in California over 2 waves of the COVID-19 pandemic to explore mitigation behaviors. We developed and validated a novel Viral Respiratory Illness Mitigation Scale (VRIMS).ResultsSeven measures loaded onto a single factor with good psychometric properties. The overall sample scale average was high over both waves, indicating that most pregnant Californians engaged in most of the strategies most of the time. Older participants, minoritized participants, those living in more urban contexts, and those surveyed during a surge reported engaging in these strategies most frequently.ConclusionsClinicians and researchers should consider using reliable, validated measures like the VRIMS to identify individuals and communities that may benefit from additional education on reducing risk for COVID-19, future respiratory pandemics, or even seasonal flu.